Dialysis companies have contributed more than $104 million to defeat an initiative on California’s Nov. 6 ballot that would limit their profits — and are on the cusp of breaking the $109 million record set by the pharmaceutical industry in 2016.
This gap in the 2010 health law means health insurance remains unaffordable for millions of Americans. For now, relief is hard to come by.
The front-runner in the California governor’s race, known for his political audacity, has officially endorsed the controversial move to create one public insurance program for all Californians. Yet he also faces formidable challenges, and liberal critics fear he’ll retreat.
Candidates are charging toward midterm elections on a platform of single-payer and universal coverage rhetoric. Yet “Medicare-for-all” and single-payer mean different things to different people.
The new guidance allows states to ask for waivers from provisions in the Affordable Care Act governing not only subsidies, but also the benefits insurers must offer in all their plans.
Explore The Database
A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years.
Sign Up For Our Email Newsletter
Stay informed by signing up for the KHN Morning Briefing and other emails: